A patient at the University of Alabama at Birmingham (UAB) became the first person in America to undergo an investigational therapy for emphysema that uses a foam sealant sprayed into the lungs.

On Oct. 29, 2012, Perry Waldrop, 55, of Cullman, Ala., was treated in a late-stage clinical trial of the AeriSeal System. The therapy, approved for use in parts of Europe and Israel, is undergoing investigation in the United States as a potential method of reducing lung volume in patients with severe emphysema.

Read story here: bit.ly/VwnUlg

# vimeo.com/60091853 Uploaded 722 Plays / / 0 Comments Watch in Couch Mode

Patient Care

uabnews Plus

UAB — home to prestigious centers for the study of cancer, neuroscience, AIDS, diabetes and more — excels at translating medical discoveries in the lab to revolutionary therapies in one of the nation’s largest academic medical centers. Professionals at


+ More

UAB — home to prestigious centers for the study of cancer, neuroscience, AIDS, diabetes and more — excels at translating medical discoveries in the lab to revolutionary therapies in one of the nation’s largest academic medical centers. Professionals at UAB Medicine use that knowledge to provide the highest quality care to more than one million patients annually in America’s third-largest hospital and its affiliated clinics.

Browse This Channel

Shout Box

Channels are a simple, beautiful way to showcase and watch videos. Browse more Channels. Channels